154 related articles for article (PubMed ID: 8788493)
21. Anxiolytic-like actions of BW 723C86 in the rat Vogel conflict test are 5-HT2B receptor mediated.
Kennett GA; Trail B; Bright F
Neuropharmacology; 1998 Dec; 37(12):1603-10. PubMed ID: 9886683
[TBL] [Abstract][Full Text] [Related]
22. A novel class of 5-HT2A receptor antagonists: aryl aminoguanidines.
Bryant HU; Nelson DL; Button D; Cole HW; Baez MB; Lucaites VL; Wainscott DB; Whitesitt C; Reel J; Simon R; Koppel GA
Life Sci; 1996; 59(15):1259-68. PubMed ID: 8845011
[TBL] [Abstract][Full Text] [Related]
23. The human serotonin 5-HT2B receptor: pharmacological link between 5-HT2 and 5-HT1D receptors.
Choi DS; Birraux G; Launay JM; Maroteaux L
FEBS Lett; 1994 Oct; 352(3):393-9. PubMed ID: 7926008
[TBL] [Abstract][Full Text] [Related]
24. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
Schreiber R; Brocco M; Audinot V; Gobert A; Veiga S; Millan MJ
J Pharmacol Exp Ther; 1995 Apr; 273(1):101-12. PubMed ID: 7714755
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors.
Knight AR; Misra A; Quirk K; Benwell K; Revell D; Kennett G; Bickerdike M
Naunyn Schmiedebergs Arch Pharmacol; 2004 Aug; 370(2):114-23. PubMed ID: 15322733
[TBL] [Abstract][Full Text] [Related]
26. m-Chlorophenylpiperazine (mCPP) is an antagonist at the cloned human 5-HT2B receptor.
Thomas DR; Gager TL; Holland V; Brown AM; Wood MD
Neuroreport; 1996 Jun; 7(9):1457-60. PubMed ID: 8856697
[TBL] [Abstract][Full Text] [Related]
27. Agonist-directed trafficking of signalling at serotonin 5-HT2A, 5-HT2B and 5-HT2C-VSV receptors mediated Gq/11 activation and calcium mobilisation in CHO cells.
Cussac D; Boutet-Robinet E; Ailhaud MC; Newman-Tancredi A; Martel JC; Danty N; Rauly-Lestienne I
Eur J Pharmacol; 2008 Oct; 594(1-3):32-8. PubMed ID: 18703043
[TBL] [Abstract][Full Text] [Related]
28. Discriminative stimulus properties of the novel serotonin (5-HT)2C receptor agonist, RO 60-0175: a pharmacological analysis.
Dekeyne A; Girardon S; Millan MJ
Neuropharmacology; 1999 Mar; 38(3):415-23. PubMed ID: 10219979
[TBL] [Abstract][Full Text] [Related]
29. The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivo.
Beattie DT; Smith JA; Marquess D; Vickery RG; Armstrong SR; Pulido-Rios T; McCullough JL; Sandlund C; Richardson C; Mai N; Humphrey PP
Br J Pharmacol; 2004 Nov; 143(5):549-60. PubMed ID: 15466450
[TBL] [Abstract][Full Text] [Related]
30. 5-Methyl-1-(3-pyridylcarbamoyl)-1,2,3,5-tetrahydropyrrolo[2,3-f]indole: a novel 5-HT2C/5-HT2B receptor antagonist with improved affinity, selectivity, and oral activity.
Forbes IT; Ham P; Booth DH; Martin RT; Thompson M; Baxter GS; Blackburn TP; Glen A; Kennett GA; Wood MD
J Med Chem; 1995 Jul; 38(14):2524-30. PubMed ID: 7629791
[TBL] [Abstract][Full Text] [Related]
31. Slow wave sleep in humans: role of 5-HT2A and 5-HT2C receptors.
Sharpley AL; Elliott JM; Attenburrow MJ; Cowen PJ
Neuropharmacology; 1994; 33(3-4):467-71. PubMed ID: 7984285
[TBL] [Abstract][Full Text] [Related]
32. The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of m-chlorophenylpiperazine.
Fiorella D; Rabin RA; Winter JC
Psychopharmacology (Berl); 1995 May; 119(2):222-30. PubMed ID: 7659770
[TBL] [Abstract][Full Text] [Related]
33. Characterisation of 5-HT2 receptor subtypes in the Suncus murinus intestine.
Javid FA; Naylor RJ
Eur J Pharmacol; 1999 Sep; 381(2-3):161-9. PubMed ID: 10554884
[TBL] [Abstract][Full Text] [Related]
34. SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist.
Kennett GA; Wood MD; Bright F; Trail B; Riley G; Holland V; Avenell KY; Stean T; Upton N; Bromidge S; Forbes IT; Brown AM; Middlemiss DN; Blackburn TP
Neuropharmacology; 1997; 36(4-5):609-20. PubMed ID: 9225286
[TBL] [Abstract][Full Text] [Related]
35. Interaction of the beta adrenergic receptor antagonist bucindolol with serotonergic receptors.
Watts SW; Fink GD; Silver PJ; Cushing DJ
J Cardiovasc Pharmacol; 2000 Jan; 35(1):29-36. PubMed ID: 10630730
[TBL] [Abstract][Full Text] [Related]
36. Recent advances in the discovery of selective and non-selective 5-HT(1D) receptor ligands.
Ward SE; Watson JM
Curr Top Med Chem; 2010; 10(5):479-92. PubMed ID: 20166947
[TBL] [Abstract][Full Text] [Related]
37. Multiple 5-HT receptors in passive avoidance: comparative studies of p-chloroamphetamine and 8-OH-DPAT.
Misane I; Ogren SO
Neuropsychopharmacology; 2000 Feb; 22(2):168-90. PubMed ID: 10649830
[TBL] [Abstract][Full Text] [Related]
38. Attenuation of haloperidol-induced catalepsy by a 5-HT2C receptor antagonist.
Reavill C; Kettle A; Holland V; Riley G; Blackburn TP
Br J Pharmacol; 1999 Feb; 126(3):572-4. PubMed ID: 10188965
[TBL] [Abstract][Full Text] [Related]
39. Contribution of serotonin (5-HT) 5-HT2 receptor subtypes to the discriminative stimulus effects of cocaine in rats.
Filip M; Bubar MJ; Cunningham KA
Psychopharmacology (Berl); 2006 Jan; 183(4):482-9. PubMed ID: 16261316
[TBL] [Abstract][Full Text] [Related]
40. Ligands for the investigation of 5-HT autoreceptor function.
Roberts C; Price GW; Middlemiss DN
Brain Res Bull; 2001 Nov; 56(5):463-9. PubMed ID: 11750791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
